Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",26392,125,1.26 [0.97-1.65],0.0834054743990898
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",27129,203,0.88 [0.70-1.10],0.2556981190224858
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",26850,1344,1.18 [1.09-1.29],6.619045719671111e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Candidiasis,27156,466,1.12 [0.97-1.29],0.1210168601671113
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,26304,3478,1.12 [1.07-1.19],1.0752112439037173e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),26541,2868,1.14 [1.07-1.20],1.3178317102919037e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,26870,1362,1.19 [1.10-1.29],2.3547522503939065e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,27050,91,0.86 [0.61-1.21],0.3845237946036773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,25310,807,1.19 [1.07-1.33],0.0013293914996776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,24484,954,1.25 [1.13-1.37],7.59502260231794e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,24502,255,1.19 [0.99-1.44],0.0675926922506264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,19062,1663,1.16 [1.08-1.26],8.632214479004136e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,24273,374,1.31 [1.12-1.52],0.0005740012870067
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,27096,1588,1.14 [1.06-1.23],0.0008554286284508
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Mycoses,27218,528,1.13 [0.99-1.29],0.0685258507620467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,26462,956,1.21 [1.10-1.33],0.0001230702108127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,27162,895,1.18 [1.07-1.30],0.0014681516434875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,25711,203,0.89 [0.70-1.11],0.2948705943407603
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other infectious diseases,27280,46,1.12 [0.71-1.76],0.6270461524871478
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other septicaemia,27048,781,1.18 [1.06-1.32],0.0021521237295932
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,27039,80,0.99 [0.70-1.42],0.9713620089335756
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Other viral diseases,27180,191,1.34 [1.09-1.65],0.0063642536574413
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",27163,174,1.23 [0.98-1.55],0.068549014417622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,25854,348,1.16 [0.98-1.37],0.076142543636527
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,25771,265,1.10 [0.91-1.33],0.3435637504554889
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,25636,128,1.46 [1.14-1.87],0.0024987407280006
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral hepatitis,27257,36,0.66 [0.38-1.14],0.1358689735195516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,27203,159,1.03 [0.80-1.32],0.8463008737066483
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Viral warts,27090,46,1.04 [0.65-1.65],0.8767600067281678
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],27122,78,1.09 [0.77-1.55],0.6359124232438594
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm,27009,244,1.15 [0.94-1.39],0.1695699467336432
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,27177,71,1.27 [0.89-1.80],0.1819159414566069
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,27173,70,1.81 [1.34-2.45],0.0001147848048704
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",27003,1205,0.99 [0.90-1.09],0.8472333988725702
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of meninges,27252,81,1.54 [1.14-2.08],0.0045729775188505
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,27210,65,1.23 [0.85-1.78],0.27367356264494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,27246,136,1.22 [0.94-1.58],0.1316326624312215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm of ovary,27196,177,0.91 [0.71-1.16],0.4251669772358284
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Ascending colon,27260,274,0.93 [0.77-1.13],0.4790980523704098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Caecum,27266,247,0.97 [0.79-1.18],0.7344888639993659
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",27195,61,0.83 [0.55-1.26],0.3845550166430413
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Descending colon,27262,155,1.04 [0.81-1.34],0.7652903671493206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Rectum,27226,277,1.09 [0.90-1.31],0.3689738825784561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,27180,487,0.95 [0.82-1.10],0.4700886565484444
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Benign neoplasm: Transverse colon,27260,288,0.81 [0.66-0.98],0.0322142016624713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Carcinoma in situ of breast,22115,137,0.89 [0.67-1.18],0.4107602197807719
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",22202,165,0.96 [0.75-1.23],0.7513856116677486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",22185,33,1.22 [0.72-2.06],0.4661519155304504
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",22218,66,1.11 [0.76-1.63],0.5883424462489037
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",27211,138,0.98 [0.74-1.28],0.85982535212196
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Haemangioma, any site",27212,136,0.93 [0.70-1.23],0.601350735773266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Leiomyoma of uterus,26286,584,0.98 [0.86-1.12],0.7716648431053881
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lung cancer and mesothelioma,19553,309,1.23 [1.04-1.46],0.0183817010149541
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Lymphoid leukaemia,22190,38,1.53 [0.99-2.37],0.0571785165868977
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",22327,175,1.10 [0.87-1.40],0.4069061546335283
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",22266,114,1.03 [0.77-1.39],0.8450568562913988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",22335,183,0.82 [0.64-1.05],0.1209289869414395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",22222,70,1.04 [0.71-1.52],0.8502221541295191
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",22221,69,1.35 [0.96-1.92],0.0876890126867838
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",22209,57,1.14 [0.76-1.72],0.5157032362005967
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",22289,137,1.11 [0.85-1.45],0.4471578483440058
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",22257,105,1.33 [1.00-1.77],0.0513675707613447
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",22236,84,0.88 [0.61-1.25],0.4720565184999599
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",22195,43,1.51 [0.99-2.30],0.0582150350390898
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,22232,80,0.83 [0.57-1.20],0.3302879022174151
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi,27015,227,1.14 [0.93-1.39],0.2176789131266684
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanocytic naevi of trunk,27233,80,1.31 [0.95-1.81],0.1036358461182976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Melanoma in situ,22187,88,1.09 [0.78-1.53],0.5957677596403634
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",22233,81,1.19 [0.85-1.67],0.3107602291394042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",22305,153,1.18 [0.92-1.51],0.1969254131171017
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",22378,226,1.02 [0.83-1.26],0.8399642184393683
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",22249,97,1.21 [0.89-1.64],0.2293680976895296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,Other benign neoplasms of skin,27052,170,0.94 [0.74-1.21],0.6360874345862728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",23089,937,0.97 [0.87-1.08],0.5485868028822183
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",23128,976,0.98 [0.88-1.09],0.6997366527534286
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,26979,370,1.01 [0.86-1.19],0.876069146665279
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,25268,106,1.62 [1.25-2.10],0.0002801574081072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,26675,66,1.37 [0.96-1.96],0.0803133698818703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,26263,2952,1.17 [1.10-1.24],5.784204959460036e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,25637,33,0.82 [0.46-1.46],0.5082888373435395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,26880,45,1.18 [0.75-1.86],0.4678506358393065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,26698,1536,1.17 [1.08-1.27],7.369695967947276e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,26698,1536,1.17 [1.08-1.27],7.369695967947276e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,25231,69,1.10 [0.76-1.60],0.6097393751306031
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,26873,1269,1.28 [1.17-1.39],8.845053902442411e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,26952,117,0.80 [0.59-1.08],0.1487726658889706
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,26662,53,1.11 [0.73-1.70],0.6219500851114831
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,26665,56,0.99 [0.65-1.52],0.9746209778207312
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,27067,232,1.04 [0.84-1.28],0.7190308712758354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,27164,61,1.42 [0.98-2.05],0.0604725408878964
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",27032,197,0.91 [0.72-1.14],0.4146152296431308
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,25737,133,1.36 [1.06-1.75],0.0151023634782286
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21965,252,1.28 [1.06-1.55],0.0106601345858239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,25855,65,1.03 [0.70-1.52],0.865773305191736
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,25851,61,1.21 [0.83-1.78],0.324209925939717
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,21764,51,1.21 [0.79-1.84],0.3876023333137759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,25007,72,1.53 [1.11-2.12],0.0100443007707062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,24648,247,1.00 [0.82-1.22],0.9928940459342
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",26838,510,1.10 [0.96-1.27],0.1633066365704212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,26616,288,1.15 [0.96-1.38],0.1375513171971983
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,26417,89,1.34 [0.99-1.82],0.0608307033865812
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression,26879,1944,1.17 [1.09-1.26],6.243713226455225e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,24125,1894,1.20 [1.12-1.29],3.165770337510684e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",21769,56,0.99 [0.64-1.52],0.9602625727978852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",24192,118,1.16 [0.88-1.53],0.298051273322044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,21996,283,1.20 [1.00-1.44],0.0466933647616281
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,21758,45,0.94 [0.58-1.54],0.8183157557520708
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,24829,3116,1.18 [1.11-1.24],6.328232177388754e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,21911,198,1.26 [1.02-1.56],0.035282804105862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,22242,529,1.21 [1.06-1.38],0.0045430216887304
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,27173,368,1.14 [0.97-1.34],0.1020273470575598
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,26989,184,1.30 [1.04-1.62],0.0185498411710529
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,21810,97,1.03 [0.74-1.42],0.8658923451041557
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",21768,55,1.16 [0.76-1.76],0.4926876361416243
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,26392,2318,1.09 [1.02-1.16],0.007701145901432
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21918,205,1.21 [0.98-1.50],0.082723616681221
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,21923,210,1.54 [1.27-1.87],1.5748285352372508e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",22242,529,1.16 [1.01-1.32],0.0333303100071012
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,21802,89,1.22 [0.89-1.69],0.2206652762339052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,26979,174,1.23 [0.98-1.55],0.0720501904013581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,22334,621,1.00 [0.88-1.14],0.968745240979352
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,22273,560,1.08 [0.95-1.24],0.240765375019221
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,24471,70,0.99 [0.67-1.44],0.9439060397388744
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,26368,4655,1.13 [1.08-1.19],4.742857477694685e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,24150,76,0.72 [0.49-1.06],0.0959959287854914
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,24165,91,0.98 [0.70-1.37],0.9007159215849494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,27078,2079,1.05 [0.98-1.13],0.1584317011608384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",27084,2079,1.05 [0.98-1.13],0.1419889129425578
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,24155,81,0.94 [0.66-1.35],0.7406745185661467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,26875,1596,1.09 [1.01-1.18],0.0261445757497266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",23221,1508,1.13 [1.04-1.22],0.0036046422256966
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,27265,183,1.35 [1.09-1.68],0.0059509584440694
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,26386,58,1.38 [0.94-2.01],0.0963648259934228
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,25410,131,1.00 [0.76-1.32],0.9782288308270728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,25475,196,1.22 [0.98-1.51],0.0751145121083067
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",21984,271,1.26 [1.05-1.51],0.0136132300048115
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,25451,140,1.67 [1.34-2.09],6.281113778654846e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1701,48,1.12 [0.70-1.78],0.6289678190919137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1814,185,1.20 [0.95-1.51],0.1193600664186345
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,25337,26,2.62 [1.73-3.97],4.870989847973464e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1685,33,1.24 [0.72-2.13],0.4322746773187905
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,26793,1482,1.49 [1.39-1.60],2.12741434906587e-27
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,26668,340,1.14 [0.96-1.34],0.1409385841957155
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,24886,485,1.03 [0.89-1.19],0.6662956536729769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,22441,728,1.20 [1.07-1.35],0.0014001421183042
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",27179,229,1.04 [0.85-1.28],0.6869670956415055
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),26270,54,1.36 [0.93-1.99],0.1169204671432985
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Angina pectoris,25749,871,1.32 [1.20-1.46],3.142026197580293e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Aortic aneurysm,26313,97,0.92 [0.66-1.27],0.6090425745990875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,26250,34,1.20 [0.72-2.01],0.4867737729513172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",26363,147,1.27 [0.99-1.61],0.0561941982089699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17746,1470,1.08 [1.00-1.18],0.0540810844130834
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,AV-block,23893,242,0.99 [0.80-1.21],0.90254637473084
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",27239,306,1.03 [0.86-1.23],0.7486858573394535
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiac arrest,16402,126,1.20 [0.92-1.57],0.1829823845051902
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cardiomyopathy,23784,133,0.97 [0.74-1.28],0.825297481728402
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",23729,78,1.22 [0.87-1.71],0.2401207557630786
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,27276,34,0.84 [0.48-1.47],0.5439402942808689
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Conduction disorders,24374,723,1.06 [0.95-1.20],0.2957710039703077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,26362,1496,1.24 [1.14-1.34],7.07051950125794e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,24514,7208,1.07 [1.03-1.11],0.0003919846816284
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,DVT of lower extremities,25775,244,1.08 [0.89-1.32],0.4343204348115415
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Endocarditis,23710,59,1.14 [0.76-1.70],0.5239555569973486
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Heart failure, strict",27183,856,1.13 [1.02-1.26],0.01847796669733
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertension,25131,6091,1.08 [1.04-1.13],8.699330473128937e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, essential",25144,6104,1.08 [1.04-1.13],7.011494351955826e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, portal",27169,43,0.73 [0.44-1.22],0.2323511996004239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19202,162,1.28 [1.02-1.61],0.0365485559101275
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,19147,107,1.73 [1.35-2.21],1.679485067536304e-05
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Hypotension,27140,1103,1.01 [0.92-1.11],0.8602580140458441
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,26525,93,1.25 [0.92-1.70],0.1522533462709395
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",26561,1683,1.21 [1.12-1.30],4.241576065995239e-07
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",26962,449,1.27 [1.10-1.46],0.000908039537153
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Left bundle-branch block,23949,298,1.07 [0.89-1.28],0.480827162592216
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,27056,602,1.16 [1.02-1.31],0.0208031895648391
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",25362,484,1.25 [1.09-1.43],0.0013292410490222
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",27253,87,1.50 [1.13-2.01],0.0057187253470305
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",27271,241,1.24 [1.02-1.50],0.030971344280743
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Oesophageal varices,25567,36,0.98 [0.57-1.68],0.9473559170671682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other aneurysm,26273,57,0.99 [0.65-1.52],0.9769115327897108
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arrhythmias,24005,354,1.10 [0.93-1.30],0.2539938008322396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,26280,64,1.30 [0.90-1.86],0.1606505724673769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,26404,188,1.29 [1.05-1.60],0.0177504551556166
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other diseases of pericardium,23807,156,1.07 [0.83-1.37],0.5959300150396721
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other disorders of veins,25629,98,0.95 [0.69-1.32],0.7638627311624532
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,25578,47,1.39 [0.92-2.11],0.1207984407356001
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,26028,40,1.00 [0.61-1.65],0.995511825582354
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,25693,162,0.90 [0.70-1.16],0.4235500186416072
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,24453,802,1.08 [0.96-1.20],0.1865349583362018
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,26081,44,0.98 [0.60-1.58],0.9191019740340776
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,26719,503,1.05 [0.91-1.21],0.5023200772793128
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,26695,318,1.11 [0.93-1.32],0.2447697867991057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",26539,551,1.09 [0.96-1.25],0.1817476893703939
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,16565,289,1.11 [0.92-1.33],0.2712106817006287
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Peripheral artery disease,26476,273,1.33 [1.12-1.59],0.0012971573397479
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),25850,319,1.11 [0.93-1.32],0.2548784681467136
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Pulmonary embolism,26828,451,1.07 [0.93-1.24],0.3468002973462005
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,27204,587,1.03 [0.91-1.18],0.6228167256218664
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Right bundle-branch block,23869,218,1.04 [0.84-1.28],0.740450433520936
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Secondary right heart disease,26686,309,1.13 [0.94-1.34],0.186540844139335
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,26149,161,1.21 [0.96-1.54],0.1105096166219087
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",26955,523,1.26 [1.10-1.43],0.0005690472305256
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",26929,570,1.25 [1.10-1.41],0.0004399170899673
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,26492,70,1.16 [0.81-1.66],0.4061180030084107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,26263,47,0.77 [0.47-1.26],0.2946887234056915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Transient ischemic attack,26729,216,1.21 [0.99-1.49],0.0629267803119981
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,26652,198,1.17 [0.94-1.46],0.1486030170783272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Varicose veins,25995,464,1.05 [0.91-1.22],0.4754707989042767
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,26227,94,1.10 [0.80-1.52],0.5503153535429784
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter IX Diseases of the circulatory system,Venous thromboembolism,27065,706,1.07 [0.96-1.21],0.2320857343453048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",27236,216,0.85 [0.68-1.06],0.1379950265309691
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",24220,1857,1.13 [1.05-1.21],0.0011846023577855
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Any mental disorder,26669,4306,1.16 [1.11-1.22],1.5240874130088608e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",27204,254,0.85 [0.70-1.05],0.1265865559959635
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",24328,1965,1.21 [1.13-1.29],5.357626643770119e-08
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",22457,94,1.16 [0.84-1.60],0.357422399431591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Smoking dependency,26869,1197,1.36 [1.26-1.48],3.6104250392225925e-14
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",23739,1376,1.27 [1.17-1.38],3.4842126814750118e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter V Mental and behavioural disorders,Vascular dementia,26773,100,0.97 [0.70-1.34],0.850749225443377
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Alzheimer disease,27280,358,1.04 [0.88-1.23],0.6073846803496337
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"AlzheimerÕs disease (Atypical or mixed), excluding more controls",18617,59,1.45 [0.97-2.15],0.0700865683966572
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Bell's palsy,25125,83,0.87 [0.61-1.25],0.4586952748125944
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,25670,628,1.13 [1.00-1.27],0.0569815185865682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral cysts,26877,222,1.03 [0.83-1.27],0.7997418241439029
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,27206,276,1.02 [0.85-1.24],0.8115249643965093
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,26790,40,1.00 [0.60-1.64],0.9850748905882212
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,27266,47,1.45 [0.96-2.19],0.0767280796549001
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",26712,57,0.93 [0.61-1.44],0.7531882269695387
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Epilepsy,25810,280,1.09 [0.91-1.31],0.3575731581775847
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,26863,1333,1.12 [1.03-1.22],0.0080685250452276
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,27232,510,1.06 [0.92-1.22],0.390860615734237
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Falls/tendency to fall,26641,2902,0.99 [0.93-1.05],0.7759689150069307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Generalized epilepsy,26911,46,0.87 [0.54-1.41],0.5750596126063687
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hemiplegia,27148,218,1.16 [0.94-1.43],0.1557882025391919
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Hydrocephalus,26722,67,1.60 [1.16-2.20],0.0040191480441863
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,27259,79,1.37 [0.99-1.89],0.0567088646658752
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of plantar nerve,25167,125,1.10 [0.83-1.45],0.5128005455474287
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,25104,62,1.14 [0.78-1.68],0.4951041684814509
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Memory loss,26647,95,1.11 [0.81-1.53],0.5202707719241231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Migraine,26029,499,1.12 [0.97-1.28],0.1129183608018236
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",27165,447,1.09 [0.94-1.26],0.2623037009451401
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Motor neuron disease,18704,121,0.94 [0.70-1.27],0.6970907607128893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,27064,144,0.93 [0.71-1.21],0.574922779907157
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",26427,1385,1.10 [1.01-1.20],0.0217139738861362
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Neurological diseases,25667,3791,1.08 [1.02-1.13],0.003653054105439
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,26911,161,0.98 [0.76-1.27],0.8906464182323632
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",25466,424,1.22 [1.05-1.41],0.0086428774627446
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",27222,235,1.17 [0.96-1.43],0.1176708979068896
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,21968,668,1.08 [0.96-1.22],0.2111877221069552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other diseases of spinal cord,26720,65,1.02 [0.69-1.51],0.9234983941428284
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other disorders of nervous system,26777,122,0.96 [0.72-1.28],0.7781472541723208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,26904,182,1.17 [0.93-1.47],0.1745737095972148
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other facial nerve disorders,25135,93,0.89 [0.63-1.25],0.5022585177794856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other headache syndromes,25605,75,1.43 [1.03-1.98],0.0314448323385068
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other neurological diseases,27160,505,1.10 [0.95-1.26],0.1935298494044733
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Other sleep disorders,25932,402,1.05 [0.90-1.22],0.5680071655772467
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Parkinson's disease,27256,312,0.99 [0.83-1.19],0.910711112848396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,26737,82,1.11 [0.79-1.57],0.5360015874741448
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Restless leg syndrome,27278,100,1.05 [0.77-1.44],0.7480118014529789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Sleep apnoea,27103,318,1.10 [0.93-1.31],0.2784042804825186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Small fibre neuropathy,27027,40,1.55 [1.02-2.36],0.0423841466679627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,27269,150,0.83 [0.63-1.09],0.1731629700737769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Trigeminal neuralgia,25108,66,1.46 [1.03-2.06],0.033292586176588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,27280,362,1.05 [0.89-1.24],0.5876469758537204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VI Diseases of the nervous system,Vascular dementia (undefined),26729,97,0.98 [0.70-1.36],0.8972371799948415
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,26699,108,0.98 [0.72-1.33],0.8772341341955407
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,26814,477,1.07 [0.93-1.24],0.3371866409216655
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,27132,170,1.41 [1.13-1.76],0.0026722304089759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,26171,62,1.20 [0.82-1.76],0.3517261214901369
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,26162,53,1.18 [0.78-1.79],0.4404280463288559
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",27159,58,1.38 [0.95-2.01],0.0945659657958339
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,26990,164,1.04 [0.81-1.33],0.7421062368638527
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1692,39,1.42 [0.88-2.28],0.1528807924664492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,2034,71,0.98 [0.67-1.44],0.9131900637832092
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,26680,89,0.72 [0.50-1.02],0.0670829606436118
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,27096,1045,1.05 [0.95-1.16],0.321791336655195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",26860,751,1.01 [0.90-1.13],0.8912650483098825
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,26399,290,0.99 [0.82-1.19],0.9191382904017892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",27185,848,1.08 [0.97-1.20],0.1843113496935134
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,27262,69,1.10 [0.76-1.60],0.6017879053585893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,27111,774,1.06 [0.94-1.18],0.3449137714704157
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",27233,407,1.00 [0.85-1.17],0.966414718458492
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,27189,200,0.98 [0.78-1.22],0.8341168811784789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,26149,40,1.50 [0.97-2.33],0.0681214014535404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,26155,46,1.45 [0.97-2.18],0.0728339257827593
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,26170,61,1.00 [0.67-1.51],0.983615893557428
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,27187,716,1.00 [0.88-1.12],0.9472017515924396
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,26650,179,0.86 [0.68-1.11],0.2485905076010755
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,26402,65,0.93 [0.62-1.38],0.7069121790484152
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,26927,101,0.84 [0.60-1.17],0.3034127433300023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,27138,312,1.03 [0.86-1.23],0.7288972771490296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,26550,213,1.03 [0.83-1.28],0.8007737152547254
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,27117,128,0.95 [0.71-1.26],0.7000940678919509
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,26942,471,1.04 [0.90-1.20],0.5989827663922928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,26745,154,1.09 [0.85-1.40],0.4980914420515606
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,25497,2509,1.03 [0.97-1.10],0.3144643647814616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,27097,271,1.01 [0.83-1.23],0.9219430815064588
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,27256,153,0.94 [0.72-1.22],0.6411917099725759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,26501,392,1.10 [0.94-1.29],0.2297784992791799
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,26889,63,0.67 [0.44-1.03],0.0706424944873977
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,27247,54,1.17 [0.77-1.76],0.4663589368685025
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,26202,93,0.76 [0.53-1.08],0.12242694672195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,26266,157,0.95 [0.74-1.23],0.7174373593686023
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,26161,110,1.17 [0.87-1.56],0.2918463598808009
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,26407,70,1.32 [0.93-1.87],0.1200551632643497
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",26110,59,0.84 [0.55-1.29],0.4290163931725627
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,26589,118,0.88 [0.65-1.19],0.4015030857548494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",26647,176,1.07 [0.84-1.35],0.5844321765450584
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,26244,135,1.21 [0.94-1.57],0.146895256442145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,26150,99,1.15 [0.85-1.57],0.3644562403419253
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,26127,76,1.19 [0.84-1.69],0.319832405840581
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,25077,2089,1.04 [0.97-1.11],0.2618635835582713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,26190,81,0.87 [0.60-1.25],0.4481432013113356
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,27018,427,0.99 [0.85-1.16],0.9141525420374054
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,26637,46,1.19 [0.77-1.86],0.4336527225264542
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),26751,160,1.11 [0.87-1.42],0.4054867477035909
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,27041,117,1.03 [0.77-1.38],0.8457891696149296
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,27234,117,1.29 [0.98-1.69],0.070489268640427
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,27153,142,1.25 [0.98-1.61],0.0764173431021011
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,26993,69,1.12 [0.78-1.62],0.5476836052135637
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Mnire disease,26991,67,0.86 [0.57-1.28],0.4486928371580989
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,27175,807,1.07 [0.96-1.20],0.2203804578783902
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,26923,555,1.05 [0.92-1.21],0.4367786279464081
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,26490,122,1.07 [0.81-1.42],0.6318130254791143
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter VIII Diseases of the ear and mastoid process,Tinnitus,26448,80,1.05 [0.74-1.50],0.7782565347458298
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute pharyngitis,27007,86,0.98 [0.69-1.38],0.8941444666758859
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,27154,233,0.97 [0.79-1.20],0.8078585408642204
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,26983,62,0.98 [0.66-1.47],0.9371963045726824
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza,25569,129,1.00 [0.75-1.32],0.9845455853115596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,All influenza (not pneumonia),25567,127,0.96 [0.72-1.27],0.7776245115996189
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic asthma (mode),19371,127,1.24 [0.95-1.63],0.1134587560209274
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Allergic rhinitis,27124,285,1.09 [0.90-1.31],0.3695265708084077
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",21107,2052,1.10 [1.03-1.18],0.0075187743559425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",21272,2028,1.11 [1.03-1.19],0.0046631780607096
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),26861,123,1.02 [0.77-1.36],0.8708531310400195
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",25506,66,1.33 [0.93-1.89],0.1176742710297476
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Bronchiectasis,23590,407,1.21 [1.05-1.41],0.0107521746410716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",23254,71,0.89 [0.60-1.31],0.5465921637625457
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,26129,2946,1.09 [1.03-1.15],0.00359085267357
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",26003,61,0.84 [0.55-1.29],0.4272239480048239
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Chronic sinusitis,26087,145,1.23 [0.96-1.58],0.1044450146680245
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",27105,1051,1.10 [1.00-1.20],0.0540284814362266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Deviated nasal septum,26013,71,1.01 [0.70-1.48],0.93901135722791
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,25205,5139,1.10 [1.06-1.15],7.1846159552117525e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",26275,333,1.10 [0.93-1.31],0.2517256602573848
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Early onset COPD,26367,313,1.14 [0.97-1.35],0.1213315121445716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Emphysema,23452,269,1.30 [1.10-1.53],0.0019480469830654
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,25654,227,1.22 [1.00-1.49],0.0473663147557993
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Influenza and pneumonia,27086,1646,1.12 [1.04-1.21],0.0038068982703894
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Interstitial lung disease,25693,266,1.14 [0.95-1.38],0.165955749470062
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Later onset COPD,26363,738,1.09 [0.97-1.22],0.1529649614964431
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Lung diseases due to external agents,27272,226,1.19 [0.97-1.46],0.0869394529788815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Nasal polyp,26007,65,0.99 [0.67-1.47],0.9566269485050146
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,27053,919,1.13 [1.02-1.25],0.0153774934900792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of pleura,27095,1750,1.08 [1.00-1.16],0.0478152978110789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,26728,786,1.14 [1.02-1.27],0.0233326319331605
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other pleural conditions,25382,37,1.11 [0.67-1.84],0.6878590914474259
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,27196,342,1.15 [0.98-1.36],0.0965199238372174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,27192,1184,1.12 [1.02-1.22],0.0141434197434758
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural effusion,26190,845,1.03 [0.93-1.15],0.5414287259856585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pleural plaque,25391,46,1.53 [1.02-2.30],0.0382016724129425
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",26851,1411,1.12 [1.03-1.22],0.0062403196981605
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,27242,196,1.18 [0.95-1.47],0.1298955613886667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pneumothorax,25436,91,1.03 [0.74-1.43],0.8543883081790302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pollen allergy,27248,238,1.08 [0.88-1.32],0.4486015440306862
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Pulmonary oedema,26918,64,1.63 [1.17-2.28],0.0039430086732495
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Respiratory insufficiency,19296,52,0.78 [0.49-1.24],0.2902006055667716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,27028,894,1.12 [1.01-1.24],0.0288606577633703
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,26227,285,1.09 [0.91-1.32],0.3400373293955147
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Viral pneumonia,25655,215,1.19 [0.97-1.47],0.0933499763650131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",26874,171,1.17 [0.93-1.48],0.1782009080589956
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,13163,109,1.39 [1.06-1.83],0.0165342781449773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,19452,38,1.16 [0.71-1.89],0.55186442666242
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute appendicitis,27096,145,0.84 [0.64-1.11],0.2227785180468811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute gastritis,20465,91,1.31 [0.97-1.78],0.079094324076161
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute pancreatitis,24992,163,1.11 [0.87-1.42],0.3859161433673609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Acute peritonitis,26710,85,1.00 [0.71-1.41],0.9920808768923762
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Alcoholic liver disease,26403,32,0.78 [0.44-1.38],0.3911166714455758
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Barrett oesophagus,20713,339,1.14 [0.96-1.34],0.1287876343513142
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",24910,81,1.64 [1.22-2.21],0.0009571618737096
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",26857,81,1.62 [1.20-2.17],0.0014879108108558
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholecystitis,25016,187,1.18 [0.95-1.48],0.1398063724438915
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Cholelithiasis,26006,1177,1.19 [1.08-1.30],0.0001714318700585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic gastritis,20717,343,1.12 [0.95-1.32],0.1871032231348272
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Chronic pancreatitis,24871,42,0.80 [0.48-1.33],0.3891548961111452
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",27198,72,0.82 [0.56-1.21],0.3171450310427226
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Coeliac disease,25721,149,1.26 [0.98-1.60],0.0662290140454889
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Collagenous colitis,25389,111,1.05 [0.78-1.42],0.7259559416164874
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,27142,150,1.08 [0.83-1.39],0.5682029989056003
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Constipation,26933,1715,1.07 [0.99-1.15],0.0779366611921126
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn disease,25372,94,1.15 [0.84-1.58],0.3768552783340713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",26926,70,1.09 [0.75-1.58],0.6604189043801728
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Crohn's disease NAS,25375,97,1.24 [0.92-1.68],0.1631877191077352
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Dental caries,26468,229,1.02 [0.83-1.26],0.8439269912919585
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,25659,2465,1.10 [1.03-1.17],0.0031253630684676
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of appendix,27138,187,0.96 [0.76-1.22],0.7464365522246057
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of liver,27178,807,1.14 [1.02-1.27],0.0204231800885516
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",24977,4603,1.04 [0.99-1.09],0.1084166370070941
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",26816,577,1.03 [0.90-1.17],0.6925020985591716
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of peritoneum,27158,533,1.10 [0.96-1.26],0.1638896374070952
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,26354,115,0.75 [0.55-1.03],0.0721614051508186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of salivary glands,26204,64,0.76 [0.50-1.15],0.1886086649804028
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of the digestive system,26973,1401,1.05 [0.97-1.14],0.2478386569879873
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diseases of tongue,26216,110,1.11 [0.83-1.49],0.4950714035979531
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",26410,1581,1.15 [1.06-1.24],0.0004185063531833
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,22617,3203,1.07 [1.01-1.13],0.0244706863996969
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Duodenal ulcer,20503,129,1.17 [0.90-1.53],0.2449700436394789
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",27227,108,1.19 [0.89-1.59],0.2497177360974777
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,27181,61,1.48 [1.03-2.12],0.0330897975030893
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,26463,92,0.91 [0.65-1.28],0.5844154175748757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,19525,111,1.13 [0.84-1.51],0.408123512436839
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Functional dyspepsia,21032,658,1.11 [0.98-1.25],0.0947916214942096
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastric ulcer,20724,350,1.03 [0.87-1.22],0.7356815640623882
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,23152,2778,1.08 [1.02-1.15],0.0075494848698928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,20846,472,1.03 [0.89-1.19],0.6616215509487344
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,21344,8410,1.06 [1.02-1.10],0.0010227628808643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,GI-bleeding,26705,1133,1.04 [0.94-1.14],0.4631855138325433
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,26302,63,0.92 [0.61-1.38],0.6893719982666378
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,20380,1258,1.16 [1.06-1.26],0.0009183404323172
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",26411,40,1.17 [0.72-1.90],0.5178791039408877
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Hernia,26095,2901,1.09 [1.03-1.15],0.0043931603006255
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impacted teeth,27191,56,1.59 [1.11-2.29],0.0123172673914285
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Impaction of intestines,19478,64,1.41 [0.99-2.01],0.0581094294435289
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Inguinal hernia,23354,160,1.01 [0.78-1.30],0.9476628840378816
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,19514,100,1.01 [0.74-1.39],0.9435605185687852
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Intestinal malabsorption,25748,176,1.24 [0.99-1.55],0.0616179772114965
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,20231,817,1.08 [0.97-1.21],0.1449308252254199
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,27263,358,1.32 [1.13-1.54],0.0004448305131725
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,26095,817,1.18 [1.06-1.31],0.002413719604406
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,26377,1099,1.11 [1.01-1.22],0.0278391176277014
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophageal obstruction,20533,159,1.00 [0.78-1.29],0.9764502985088616
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oesophagitis,20945,571,1.10 [0.97-1.25],0.1468642238112405
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,27232,157,0.99 [0.77-1.28],0.957689963808609
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,23253,59,1.48 [1.03-2.13],0.0359874991225137
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,20682,1268,1.12 [1.03-1.22],0.0089894875864563
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,25129,300,1.15 [0.96-1.38],0.1178989231908484
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of gallbladder,25014,185,1.00 [0.79-1.26],0.9938033685095392
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestine,20998,1584,1.07 [0.99-1.15],0.1121144879818681
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of intestines,25129,5715,1.06 [1.02-1.10],0.0057198616193418
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,26207,233,0.98 [0.79-1.20],0.8186076190237928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of liver,27052,681,1.18 [1.05-1.33],0.0052501122829686
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,20953,579,1.10 [0.97-1.25],0.1471209930693955
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of pancreas,24987,158,1.21 [0.95-1.53],0.1256238894464892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,27096,471,1.09 [0.95-1.26],0.2178515713423126
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,21455,1081,1.01 [0.92-1.11],0.866756009646213
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,26723,1151,1.04 [0.95-1.14],0.4332398833160119
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,26426,187,1.04 [0.83-1.31],0.7330239819068329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,21180,1766,1.08 [1.01-1.17],0.0319048512094201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),22485,2111,1.09 [1.02-1.16],0.0164223944657265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,26468,97,0.87 [0.62-1.21],0.4003326377560865
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,26243,965,1.13 [1.02-1.25],0.0145546916242351
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",19743,329,1.14 [0.96-1.35],0.1262046383589892
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,27170,69,1.42 [1.01-2.01],0.0450263844084878
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,19905,491,1.05 [0.91-1.21],0.5299968568440027
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",25701,129,0.93 [0.70-1.23],0.594359588440468
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Recurring oral aphthae,27271,69,1.04 [0.71-1.51],0.8481837790337359
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Stomatitis and related lesions,26242,127,1.04 [0.79-1.37],0.7752549727350682
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Toxic colitis,25345,67,0.91 [0.61-1.36],0.6498860832464811
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,20600,226,1.22 [1.00-1.49],0.0448763671160988
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ulcerative colitis,25445,167,1.21 [0.96-1.52],0.1114296122918942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",25414,136,1.18 [0.91-1.53],0.2231861821779865
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Umbilical hernia,23369,175,1.00 [0.79-1.27],0.9942081677849446
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,19600,186,1.16 [0.93-1.45],0.1924162909861392
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Ventral hernia,23452,258,1.12 [0.92-1.36],0.2450058144569924
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XI Diseases of the digestive system,Volvulus,19501,87,0.72 [0.50-1.04],0.0763361670413861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,27191,258,1.13 [0.93-1.37],0.2106762701492636
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,26957,78,1.01 [0.70-1.44],0.9640109657002912
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,25223,213,0.92 [0.73-1.15],0.4518732952773963
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,26753,626,1.07 [0.95-1.21],0.2787291213112906
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",26270,143,1.11 [0.86-1.43],0.4396077107550733
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,25348,338,1.10 [0.93-1.30],0.2781842098357923
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,26971,279,1.02 [0.84-1.23],0.8491001091394319
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,27172,480,1.04 [0.90-1.20],0.6071915321428822
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,26742,50,1.76 [1.23-2.53],0.00222960141974
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,25682,3154,1.01 [0.96-1.07],0.6873786823706891
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,26828,477,1.00 [0.86-1.15],0.9461538662879382
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,26682,331,1.03 [0.87-1.22],0.7371730626626116
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,26965,838,1.07 [0.96-1.19],0.2230433872763582
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",27256,78,1.08 [0.75-1.54],0.685656942122832
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,25100,90,0.68 [0.48-0.97],0.0323944649936352
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,26396,45,0.72 [0.44-1.18],0.1936325137529234
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,26957,265,1.03 [0.84-1.24],0.7989831967727201
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,25419,409,0.96 [0.82-1.13],0.6094910901391174
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,25057,47,1.13 [0.72-1.76],0.5983251482918411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,27176,83,0.87 [0.61-1.24],0.4278182153947384
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,26287,160,1.25 [0.99-1.58],0.0649301291131303
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,27047,168,0.74 [0.57-0.96],0.0225194924846701
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,26747,55,0.90 [0.58-1.40],0.6335559572929095
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,25074,64,1.22 [0.84-1.78],0.2915768090209642
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,26588,1578,0.96 [0.88-1.04],0.3079548069739098
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",25454,444,0.95 [0.81-1.10],0.4914489941557171
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,25062,52,1.11 [0.72-1.69],0.642073895603861
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,27193,314,0.87 [0.72-1.05],0.1364172989141317
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,26774,82,0.80 [0.56-1.16],0.2427478203094957
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,27119,240,0.83 [0.67-1.02],0.0770734598419671
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,27227,294,1.09 [0.91-1.30],0.3702340331270338
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,25164,154,0.93 [0.72-1.21],0.6088181190799464
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,25270,260,0.80 [0.65-0.99],0.0401039158231231
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,27212,279,1.08 [0.89-1.30],0.4302294922554579
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",25208,198,1.31 [1.07-1.62],0.0105459716832065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,27243,150,0.94 [0.72-1.22],0.6509113093071976
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,23264,126,1.19 [0.91-1.57],0.2065462423068735
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,24770,6355,1.03 [0.99-1.07],0.1185740115754145
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,23388,4973,1.04 [0.99-1.09],0.0959919612826089
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,23217,79,1.07 [0.75-1.53],0.6906873068590206
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,23381,152,0.94 [0.72-1.22],0.6218591812506655
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,23437,208,0.95 [0.76-1.19],0.6631993486133646
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,26993,115,0.71 [0.52-0.97],0.0322593739954056
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",23349,120,1.01 [0.75-1.35],0.9440292154401364
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,19771,1356,1.03 [0.95-1.12],0.494230944444309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",27126,220,1.17 [0.95-1.43],0.1400994600276481
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,23837,608,0.98 [0.86-1.12],0.7855935250918622
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,22915,8084,1.03 [1.00-1.07],0.0646256923851761
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,24426,134,0.89 [0.67-1.18],0.4217405321074404
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,23270,132,1.10 [0.84-1.44],0.5065474115745598
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,23825,687,1.03 [0.92-1.17],0.5837944935191326
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,26260,3031,1.06 [1.00-1.12],0.0500168248322576
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,23313,175,0.78 [0.60-1.00],0.0510511841756935
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,23516,378,1.23 [1.05-1.43],0.010065996119888
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,23310,172,1.04 [0.82-1.33],0.7363158912155306
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,26333,104,0.98 [0.72-1.35],0.9194622207922052
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,20300,1885,1.04 [0.97-1.12],0.2515365827744299
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,18638,223,1.31 [1.07-1.60],0.0080862491800121
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",27265,220,1.29 [1.05-1.58],0.0136482580423353
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,18514,99,0.98 [0.70-1.35],0.880281003099307
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),18980,565,1.00 [0.87-1.14],0.9713760705923022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,23473,335,0.92 [0.77-1.10],0.3452770522026648
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,19051,636,1.04 [0.92-1.18],0.4981917595915506
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,23297,68,1.03 [0.70-1.52],0.8832991403443842
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,23950,721,1.08 [0.96-1.21],0.189732341670809
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,23566,337,1.20 [1.01-1.41],0.0357656578767747
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,19011,596,1.07 [0.94-1.22],0.3027560068709266
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,23229,91,1.09 [0.79-1.51],0.5982592604598368
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",23208,70,1.04 [0.71-1.52],0.8285551574124559
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,24344,52,1.84 [1.30-2.60],0.0006025455575556
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,26799,2507,0.93 [0.87-0.99],0.0279124513655928
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,26096,1804,0.95 [0.88-1.02],0.1716437160181751
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",27081,599,1.13 [0.99-1.28],0.0653625343371713
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,21440,3025,1.06 [1.00-1.12],0.0479323090468181
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,18488,73,1.22 [0.85-1.74],0.2777367630121302
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,23239,101,1.28 [0.95-1.72],0.1003307133474131
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,18457,42,0.88 [0.53-1.47],0.6328281349483208
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),18613,198,0.93 [0.74-1.18],0.5636219314345591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,24581,289,0.83 [0.68-1.00],0.0552239324429156
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,24878,586,0.85 [0.74-0.98],0.0229816276428815
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,27249,111,1.07 [0.79-1.43],0.6736960416078699
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",25275,2046,1.06 [0.99-1.13],0.1122853632128644
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,23270,132,1.56 [1.23-1.98],0.0002771024931086
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),18640,225,0.84 [0.67-1.05],0.1309215673186015
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,24040,811,1.10 [0.99-1.23],0.0818821004630215
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,20956,2541,1.00 [0.94-1.07],0.8982566094198561
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,26357,128,1.02 [0.77-1.35],0.8740718821758022
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,27259,77,1.04 [0.72-1.48],0.8502898047963415
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,23221,83,0.95 [0.67-1.35],0.7892306125946864
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",24614,1476,1.14 [1.05-1.23],0.001703660950309
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,23219,81,1.01 [0.71-1.44],0.9475590229944874
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,20412,1997,1.11 [1.04-1.19],0.0023719463985193
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,24425,133,0.83 [0.62-1.10],0.1977305561609737
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,23201,63,0.84 [0.55-1.28],0.4256323875911417
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,23427,198,0.87 [0.69-1.10],0.2372406442511769
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,23729,591,1.16 [1.02-1.32],0.0226913766403909
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,26732,503,1.06 [0.92-1.22],0.3857417881704101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,23879,650,1.02 [0.90-1.15],0.8094329860555696
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,27094,578,1.13 [1.00-1.29],0.0523736285595665
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,27250,67,1.03 [0.70-1.51],0.8818785620129277
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,23363,225,1.07 [0.86-1.32],0.5500632738312508
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,20923,925,1.04 [0.94-1.16],0.441067467746329
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,23805,667,1.13 [1.00-1.27],0.0452662321852757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],23263,125,0.92 [0.69-1.24],0.5890198528996803
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",18492,77,1.05 [0.73-1.51],0.7763746427103273
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,21055,2640,1.12 [1.05-1.19],0.0002553419938794
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,19250,835,1.14 [1.02-1.27],0.0177286750810268
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,26527,298,1.08 [0.90-1.30],0.3979293876987335
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",27222,84,1.18 [0.85-1.65],0.3228961882098536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",24967,51,1.52 [1.02-2.25],0.0378146859539643
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,18493,78,1.02 [0.71-1.46],0.9189431375076116
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,23342,113,1.04 [0.77-1.40],0.7984656552120621
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,19017,602,1.15 [1.02-1.31],0.0276787070814065
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,23472,334,0.92 [0.77-1.10],0.3552435148913363
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,23518,289,1.25 [1.04-1.49],0.0145938523937494
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,23510,281,1.00 [0.82-1.21],0.985931672683814
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,21052,86,1.22 [0.88-1.69],0.2239234113925462
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",27257,74,1.00 [0.70-1.45],0.983097435154264
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,23780,642,0.95 [0.84-1.08],0.4724598909786477
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sjgren],26386,157,1.07 [0.83-1.37],0.6207858557977411
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,25951,2813,1.07 [1.01-1.14],0.0253680566147186
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",23293,155,0.93 [0.72-1.21],0.5878259536631942
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,23798,569,1.09 [0.96-1.25],0.1844957156192095
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,25567,263,0.92 [0.76-1.13],0.4293866889603422
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,23507,278,0.98 [0.81-1.19],0.8554154968532539
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,24988,1759,1.07 [0.99-1.15],0.0744513381595596
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,24427,1198,1.08 [0.98-1.18],0.1116486473748179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],23202,64,1.21 [0.83-1.77],0.3249387762500182
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,26450,221,0.80 [0.64-1.00],0.0456313031225821
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,23338,200,1.11 [0.89-1.38],0.3734018992556875
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,23265,127,0.90 [0.67-1.20],0.4718049436950746
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),18471,56,1.16 [0.77-1.76],0.4774042408776295
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Acute renal failure,26202,1255,1.31 [1.21-1.43],1.373539229197093e-10
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),20389,100,0.99 [0.72-1.36],0.9466032071064048
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,26575,110,0.79 [0.57-1.08],0.1392980115438607
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,27117,235,1.26 [1.04-1.53],0.0192985358920509
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,26909,27,0.93 [0.50-1.75],0.826772370609076
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,26437,1490,1.21 [1.12-1.31],1.4079000344742995e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,27103,79,1.40 [1.02-1.94],0.039971706219947
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cyst of kidney,27070,242,1.08 [0.88-1.31],0.4744108814797487
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Cystitis,24073,251,0.98 [0.80-1.20],0.8698761337522916
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Dialysis,25002,55,2.09 [1.54-2.84],2.433584388356533e-06
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Disorders of breast,26806,341,0.90 [0.76-1.08],0.251656698475539
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Endometriosis,20468,179,0.91 [0.71-1.16],0.440483541686127
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",20690,401,0.98 [0.84-1.15],0.8413755715721569
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21291,1002,1.12 [1.01-1.23],0.029038934473591
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,21221,5050,1.08 [1.03-1.12],0.0012816131067856
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,27089,65,1.36 [0.95-1.95],0.0944018922154549
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Hydronephrosis,24826,211,1.26 [1.02-1.54],0.0296831181498114
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,26731,405,0.89 [0.76-1.05],0.1621529889111179
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Irregular menses,26811,128,0.91 [0.68-1.21],0.5161419781247737
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Menorrhagia,20598,309,1.04 [0.86-1.24],0.7060598172012265
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,23897,75,1.54 [1.13-2.11],0.0067541707780016
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,22750,2461,1.02 [0.95-1.08],0.5940958877775552
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,20433,144,1.02 [0.78-1.32],0.9078178019607276
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",27264,62,1.04 [0.70-1.56],0.8438974126007801
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",27268,77,0.92 [0.64-1.34],0.6783773621945203
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,26045,2223,1.09 [1.02-1.16],0.0139578781413273
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,24289,467,0.99 [0.85-1.15],0.8872441638551107
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,26584,119,0.97 [0.72-1.30],0.8189940238874323
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,27218,390,1.28 [1.10-1.48],0.0013401686387441
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,27219,93,1.01 [0.73-1.41],0.9517146246573774
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,25730,1908,1.14 [1.06-1.22],0.0003663583054773
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,26537,211,0.95 [0.76-1.19],0.6594251156913905
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,20439,150,1.27 [1.00-1.62],0.0534719828428767
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",20659,370,1.00 [0.85-1.18],0.9540225068919792
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20401,112,1.27 [0.96-1.68],0.0937937284828597
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,20492,203,1.05 [0.84-1.31],0.6506869946478163
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,24878,263,1.22 [1.01-1.47],0.0367391182500101
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,26955,127,1.50 [1.18-1.91],0.0009328107890038
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,20601,312,0.94 [0.79-1.13],0.5249378746445759
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,20397,108,0.77 [0.56-1.07],0.1160906791376681
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,20940,651,1.02 [0.90-1.16],0.723780800031536
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,20452,163,1.33 [1.06-1.67],0.0134989399022757
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,20878,589,1.02 [0.89-1.16],0.8205204346881381
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,27060,36,1.15 [0.69-1.91],0.5834594024946667
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,27082,2467,1.20 [1.13-1.28],2.459180021333359e-09
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",24779,164,1.10 [0.86-1.40],0.4543195728216311
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,25050,103,1.16 [0.86-1.57],0.3406265113948685
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,26917,35,1.21 [0.72-2.01],0.4700089999313044
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urethral stricture,23966,144,1.31 [1.03-1.67],0.0284703076969836
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Urolithiasis,27151,269,1.20 [0.99-1.44],0.0585737298608611
PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,Chapter XIV Diseases of the genitourinary system,Uterine polyps,20432,143,1.02 [0.79-1.33],0.8574924645082457
